IPP Bureau
Mandaviya inaugurates new headquarters of the National Dental Commission
By IPP Bureau - February 06, 2024
Additionally, an MoU was signed between the Dental Council of India and Quality Council of India for the assessment and rating of undergraduate dental colleges
Unichem Laboratories posts Q3 FY24 consolidated PAT at Rs. 83.99 Cr
By IPP Bureau - February 06, 2024
Unichem Laboratories has reported total income of Rs. 445.65 crores during the period ended December 31, 2023
Sun Pharma Advanced Research Company Q3 FY24 loss at Rs. 99.65 Cr
By IPP Bureau - February 06, 2024
Sun Pharma Advanced Research Company has reported total income of Rs. 20.25 crores during the period ended December 31, 2023
RPG Life Sciences posts Q3 FY24 PAT at Rs. 26.46 Cr
By IPP Bureau - February 05, 2024
RPG Life Sciences Limited has reported total income of Rs. 155.62 crores during the period ended December 31, 2023
TTK Healthcare posts Q3 FY24 PAT at Rs. 12.89 Cr
By IPP Bureau - February 05, 2024
TTK Healthcare has reported total income of Rs. 199.75 crores during the period ended December 31, 2023
KIMS posts Q3 FY24 consolidated PAT at Rs. 71.84 Cr
By IPP Bureau - February 05, 2024
KIMS has reported total income of Rs. 609.091 crores during the period ended December 31, 2023
Mandaviya inaugurates 24 health infrastructure facilities across AIIMS
By IPP Bureau - February 05, 2024
Delivers keynote address at the 4th convocation of AIIMS Jodhpur
DPIIT recognises 1, 17,254 startups as on Dec 2023
By IPP Bureau - February 03, 2024
At least one recognised startup in every State and UT; spread across over 80% of districts
Abbott India posts Q3 FY24 PAT at Rs. 310.98 Cr
By IPP Bureau - February 03, 2024
Abbott India has reported total income of Rs. 1492.75 crores during the period ended December 31, 2023
Thyrocare Technologies posts Q3 FY24 consolidated PAT at Rs. 15.35 Cr
By IPP Bureau - February 03, 2024
Thyrocare Technologies has reported total income of Rs. 137.47 crores during the period ended December 31, 2023
Dr Lal Path Labs posts Q3 FY24 consolidated PAT at Rs. 81.3 Cr
By IPP Bureau - February 03, 2024
Dr. Lal Path Labs has reported total income of Rs. 557.2 crores during the period ended December 31, 2023
GMM Pfaudler posts Q3 FY24 consolidated PAT at Rs. 31.72 Cr
By IPP Bureau - February 03, 2024
GMM Pfaudler has reported total income of Rs. 848.28 crores during the period ended December 31, 2023
Industry’s reaction to Union Budget 2024-25
By IPP Bureau - February 02, 2024
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
Max Healthcare Institute Ltd Q3 FY24 consolidated profit up at Rs. 289.34 Cr
By IPP Bureau - February 02, 2024
Max Healthcare Institute has reported total income of Rs. 1380.99 crores during the period ended December 31, 2023
